Corcept Therapeutics Incorporated (CORT)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The data provided for Corcept Therapeutics Incorporated indicates that the days of sales outstanding (DSO) metric is not available for the periods presented, as denoted by "— days" across all the dates from March 31, 2020, to December 31, 2024.
DSO is a measure of how long it takes a company to collect its accounts receivable. It is calculated by dividing accounts receivable by average daily sales. A lower DSO generally signifies that a company is collecting receivables more quickly, whereas a higher DSO may indicate potential issues with collecting payment from customers in a timely manner.
In this instance, the absence of data for DSO limits our ability to assess Corcept Therapeutics' efficiency in converting its accounts receivable into cash. It may be beneficial for stakeholders to explore the reasons behind the unavailability of this metric and potentially seek more up-to-date financial information to evaluate the company's collections management and working capital efficiency.
Peer comparison
Dec 31, 2024